Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplindore MR in Early Parkinson Disease
NCT00809302Phase 2Terminated
- Sponsor
- Neurogen
- Start
- Dec 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aplindore in Parkinson's disease (PD), sponsored by Neurogen. Started Dec 2008; status: terminated.
02
Drugs
aplindore
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00809302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809302.